Back to Results
First PageMeta Content
Antifungals / Piperazines / Organochlorides / Triazoles / Organofluorides / Basilea Pharmaceutica / Cephalosporin / Ceftobiprole / Methicillin-resistant Staphylococcus aureus / Organic chemistry / Chemistry / Microbiology


Microsoft Word - 20150424_FINAL_ECCMID_EN_with links.docx
Add to Reading List

Open Document

File Size: 87,52 KB

Share Result on Facebook

City

Copenhagen / Basel / /

Company

Basilea Pharmaceutica International Ltd. / Basilea Basilea Pharmaceutica Ltd. / Basilea Pharmaceutica Ltd. / S. Magnet S. P. / Astellas Pharma Inc. / 5 Basilea Pharmaceutica Ltd. / Alteon Inc. / /

Continent

Europe / /

Country

Germany / Switzerland / Italy / Sweden / Norway / Belgium / France / Austria / United States / United Kingdom / Luxembourg / Finland / Spain / Ireland / Denmark / /

Currency

pence / /

/

Event

FDA Phase / Business Partnership / Product Issues / /

Facility

D. Garner / /

IndustryTerm

pneumonia treatment / investigational product / pharmaceutical products / biopharmaceutical company developing products / /

MedicalCondition

mouse infection / drug hypersensitivity / headache / Seizures / Stevens Johnson syndrome / fungal meningitis / convulsion / severe hepatic injury / nausea / murine lung infection / anaphylaxis / invasive mould infections / respiratory tract infections / severe hypersensitivity / murine thigh infection / hypoesthesia / mucormycosis / hypersensitivity / diarrhea / urinary tract infections / community-acquired pneumonia / hepatitis / constipation / confusional state / liver disease / back pain / fungal infections / hypotension / invasive aspergillosis / MRSA pneumonia / pneumonia / invasive mucormycosis / cancer / occasionally fatal hypersensitivity / bacterial infections / disease / respiratory failure / dyspnea / hospital-acquired pneumonia / chills / dysgeusia / non-severe hypersensitivity / pruritic rash / mixed fungal infections / Serious hypersensitivity / susceptible Pseudomonas / vomiting / familial short QT syndrome / invasive fungal disease / hepatic failure / urticaria / epilepsy / infection / invasive fungal infections / dizziness / hospital-acquired respiratory-tract infections / cough / common infectious diseases / hypokalemia / paresthesia / cholestasis / acute renal failure / disorders / hematologic malignancy / /

MedicalTreatment

dose fractionation / antibiotic therapy / /

NaturalFeature

Andes / /

Organization

Congress / European Medicines Agency / U.S. Food and Drug Administration / /

Person

Stevens Johnson / G. Melchers / J. G. Melchers / Nils Schröder / Barbara Zink / /

/

Position

physician / MBA Head Public Relations & Head Corporate Development Corporate Communications / Governor / /

Product

linezolid / carbamazepine / rifampin / ceftazidime / ketoconazole / epidural steroid / BAL30072 / United States / /

Technology

pharmacokinetics / Chemotherapy / /

URL

www.eccmid.org / http /

SocialTag